201 related articles for article (PubMed ID: 7624274)
1. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
[TBL] [Abstract][Full Text] [Related]
2. Muscle weakness in mechanically ventilated patients with severe asthma.
Leatherman JW; Fluegel WL; David WS; Davies SF; Iber C
Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
[TBL] [Abstract][Full Text] [Related]
3. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
[TBL] [Abstract][Full Text] [Related]
4. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
Mehta MP; Sokoll MD; Gergis SD
Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
[TBL] [Abstract][Full Text] [Related]
5. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium.
Bevan DR; Smith CE; Donati F
Anesthesiology; 1988 Aug; 69(2):272-6. PubMed ID: 2900612
[No Abstract] [Full Text] [Related]
6. [Atracurium, vecuronium and pancuronium. Results of a polygraphic study].
Bifarini G; Tesoro S; Favetta P; Cirulli P; Paoletti F; Ciammitti C
Minerva Anestesiol; 1989 Nov; 55(11):457-62. PubMed ID: 2576684
[TBL] [Abstract][Full Text] [Related]
7. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
May JR; Rutkowski AF
J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the degree of muscle blockade: a comparative study using electromyography of the muscular relaxation induced by pancuronium, atracurium and vecuronium].
Cabarrocas E; Roigé J; Durán L; Gancedo V; Ballvé M; Martínez Bayón MJ
Rev Esp Anestesiol Reanim; 1990; 37(3):137-41. PubMed ID: 1975113
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the effects of midazolam and thiopental on the neuromuscular response of vecuronium, atracurium, and pancuronium].
Alvarez Gómez JA; Estelles Montesinos ME; Palacios Sánchez MA
Rev Esp Anestesiol Reanim; 1991; 38(5):293-6. PubMed ID: 1686499
[TBL] [Abstract][Full Text] [Related]
10. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
Barohn RJ; Jackson CE; Rogers SJ; Ridings LW; McVey AL
Muscle Nerve; 1994 Jun; 17(6):647-54. PubMed ID: 7910951
[TBL] [Abstract][Full Text] [Related]
11. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
Gramstad L
Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
Clarens DM; Kelly KJ; Gilliland SS; Kohls PK; Nahum A; Vance-Bryan K
Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium.
Haines M
AANA J; 1993 Dec; 61(6):592-6. PubMed ID: 7903505
[TBL] [Abstract][Full Text] [Related]
14. Acute necrotizing myopathy of intensive care: electrophysiological studies.
Zochodne DW; Ramsay DA; Saly V; Shelley S; Moffatt S
Muscle Nerve; 1994 Mar; 17(3):285-92. PubMed ID: 7906383
[TBL] [Abstract][Full Text] [Related]
15. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
Frankel H; Jeng J; Tilly E; St Andre A; Champion H
Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
[TBL] [Abstract][Full Text] [Related]
16. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium.
Berg H; Roed J; Viby-Mogensen J; Mortensen CR; Engbaek J; Skovgaard LT; Krintel JJ
Acta Anaesthesiol Scand; 1997 Oct; 41(9):1095-1103. PubMed ID: 9366929
[TBL] [Abstract][Full Text] [Related]
17. Persistent paralysis in critically ill patients after long-term administration of vecuronium.
Segredo V; Caldwell JE; Matthay MA; Sharma ML; Gruenke LD; Miller RD
N Engl J Med; 1992 Aug; 327(8):524-8. PubMed ID: 1353252
[TBL] [Abstract][Full Text] [Related]
18. Postoperative neuromuscular function in pediatric day-care patients.
Baxter MR; Bevan JC; Samuel J; Donati F; Bevan DR
Anesth Analg; 1991 Apr; 72(4):504-8. PubMed ID: 1672489
[TBL] [Abstract][Full Text] [Related]
19. Interactions of vecuronium and atracurium in an in vitro nerve-muscle preparation.
Van der Spek AF; Zupan JT; Pollard BJ; Schork MA
Anesth Analg; 1988 Mar; 67(3):240-6. PubMed ID: 2894184
[TBL] [Abstract][Full Text] [Related]
20. [Newly developed muscle relaxants].
Fukushima K
Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
